(S (NP (NNP COVID) (HYPH -) (NNP 19)) (VP (VBZ has) (VP (VBN created) (NP (NP (DT a) (JJ global) (NN pandemic)) (PP (IN with) (NP (JJ high) (NN morbidity) (CC and) (NN mortality)))) (PP (IN in) (NP (CD 2020))))) (. .))
(S (NP (NP (JJ Novel) (NN coronavirus) (-LRB- -LRB-) (NN nCoV) (-RRB- -RRB-)) (, ,) (VP (ADVP (RB also)) (VBN known) (PP (IN as) (NP (NP (JJ Severe) (NNP Acute) (NNP Respiratory) (NNP Syndrome) (NNP Coronavirus)) (NP-TMP (CD 2)))) (PRN (-LRB- -LRB-) (NP (NNP SARS) (HYPH -) (NNP CoV2)) (-RRB- -RRB-))) (, ,)) (VP (VBZ is) (ADJP (JJ responsible) (PP (IN for) (NP (DT this) (JJ deadly) (NN disease))))) (. .))
(S (NP (NP (NNP International) (NNP Committee)) (PP (IN on) (NP (NP (NNP Taxonomy)) (PP (IN of) (NP (NNPS Viruses))))) (PRN (-LRB- -LRB-) (NP (NNP ICTV)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN declared) (SBAR (IN that) (S (NP (NNP nCoV)) (VP (VBZ is) (NP (NP (ADJP (ADJP (RB highly) (RB genetically) (JJ similar)) (PP (IN to) (NP (NNP SARS) (HYPH -) (NNP CoV)))) (NN epidemic)) (PP (IN in) (NP (CD 2003))))))) (PRN (-LRB- -LRB-) (NP (NML (CD 89) (NN %)) (NN similarity)) (-RRB- -RRB-)))) (. .))
(S (NP (NP (JJ Limited) (NN number)) (PP (IN of) (NP (ADJP (RB clinically) (VBN validated)) (NML (JJ Human) (HYPH -) (NN nCoV)) (NML (NN protein) (NN interaction)) (NNS data)))) (VP (VBZ is) (ADJP (JJ available) (PP (IN in) (NP (DT the) (NN literature))))) (. .))
(S (PP (IN With) (NP (DT this) (NN hypothesis))) (, ,) (NP (DT the) (JJ present) (NN work)) (VP (VBZ focuses) (PP (IN on) (S (VP (VP (VBG developing) (NP (NP (DT a) (JJ computational) (NN model)) (PP (IN for) (NP (NML (NML (NN nCoV)) (HYPH -) (NML (JJ Human) (NN protein))) (NN interaction) (NN network))))) (, ,) (VP (VBG using) (NP (NP (DT the) (ADJP (RB experimentally) (VBN validated)) (NML (NNP SARS) (HYPH -) (NNP CoV) (HYPH -) (NNP Human)) (NN protein)) (NP (NNS interactions)))))))) (. .))
(S (ADVP (RB Initially)) (, ,) (NP (NML (NML (NN level) (HYPH -) (CD 1)) (CC and) (NML (NN level) (HYPH -) (CD 2))) (NML (JJ human) (NN spreader)) (NN proteins)) (VP (VBP are) (VP (VBN identified) (PP (IN in) (NP (NML (NNP SARS) (HYPH -) (NNP CoV) (HYPH -) (NNP Human)) (NN interaction) (NN network))) (, ,) (S (VP (VBG using) (NP (NP (ADJP (JJ Susceptible) (HYPH -) (JJ Infected) (HYPH -) (JJ Susceptible))) (NP (-LRB- -LRB-) (NNP SIS) (-RRB- -RRB-) (NN model))))))) (. .))
(S (NP (DT These) (NNS proteins)) (VP (VBP are) (VP (VBN considered) (PP (IN as) (NP (NP (JJ potential) (JJ human) (NNS targets)) (PP (IN for) (NP (NNP nCoV) (NN bait) (NN proteins))))))) (. .))
(S (NP (DT A) (ADJP (NP (NN gene) (HYPH -) (NN ontology)) (VBN based)) (NML (JJ fuzzy) (NN affinity)) (NN function)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (S (VP (TO to) (VP (VB construct) (NP (DT the) (NML (NML (NN nCoV)) (HYPH -) (NML (JJ Human) (NN protein))) (NN interaction) (NN network)) (PP (IN at) (NP (NML (CD 99.98) (NN %)) (NN specificity) (NN threshold))))))))) (. .))
(S (NP (DT This)) (ADVP (RB also)) (VP (VBZ identifies) (NP (DT the) (NML (NN level) (HYPH -) (CD 1)) (JJ human) (NNS spreaders)) (PP (IN for) (NP (NP (NN COVID) (HYPH -) (CD 19)) (PP (IN in) (NP (JJ human) (NML (NN protein) (HYPH -) (NN interaction)) (NN network)))))) (. .))
(S (NP (NML (NN Level) (HYPH -) (CD 2)) (JJ human) (NNS spreaders)) (VP (VBP are) (ADVP (RB subsequently)) (VP (VBN identified) (S (VP (VBG using) (NP (DT the) (NNP SIS) (NN model)))))) (. .))
(S (NP (DT The) (NML (VBN derived) (NN host) (HYPH -) (NN pathogen)) (NN interaction) (NN network)) (VP (VBZ is) (ADVP (RB finally)) (VP (VBN validated) (S (VP (VBG using) (NP (NP (CD 7) (JJ potential) (ADJP (NNP FDA) (VBN listed)) (NNS drugs)) (PP (IN for) (NP (NP (NN COVID) (HYPH -) (CD 19)) (PP (IN with) (NP (NP (JJ significant) (NN overlap)) (PP (IN between) (NP (NP (DT the) (VBN known) (NN drug) (NN target) (NN proteins)) (CC and) (NP (DT the) (VBN identified) (NN spreader) (NN proteins))))))))))))) (. .))
